Universe Pharmaceuticals (UPC) Total Liabilities (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Total Liabilities data on file, last reported at $13.2 billion in Q3 2025.

• For the quarter ending Q3 2025, Total Liabilities fell 41.32% year-over-year to $13.2 billion; the trailing twelve-month figure through Sep 2025 stood at $13.2 billion (down 41.32% YoY), and the FY2025 full-year result was $13.2 billion, down 41.32% from the prior year.
• Total Liabilities declined to $13.2 billion in Q3 2025, from $22.5 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $22.5 billion in Q3 2024 to a low of $13.8 million in Q3 2023.
• A 5-year average of $4.5 billion and a median of $70.3 million in 2021 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities surged 243521825.1% in 2021 and sank 76.9% in 2023, its largest moves.
• Tracing UPC's Total Liabilities over 5 years: stood at $70.1 million in 2021, then retreated by 15.12% to $59.5 million in 2022, then slumped by 76.9% to $13.8 million in 2023, then jumped by 163124.63% to $22.5 billion in 2024, then tumbled by 41.32% to $13.2 billion in 2025.
• Business Quant data shows UPC's Total Liabilities at $13.2 billion in Q3 2025, $22.5 billion in Q3 2024, and $22.7 million in Q1 2024.